November 2022: The Voters Have Spoken. Now What? A Discussion with Medtech Leaders
Co-hosted by: Stephen Parente, PhD and Thom Gunderson MBA
Featuring: John Michael O'Brien, President and CEO of the National Pharmaceutical Council, and Clayton Hall, Executive VP of Government Affairs at the Medical Device Manufacturers Association
Previously Recorded Lab Chats
Medical Technology Commercialization Bootcamp Seminars!
Innovation to Impact is an opportunity for med tech innovators to see "eye to eye" at a series of hybrid events. Recordings of the seminars are available below!
Medical Price Transparency
Implications of new price transparency rules to health systems, providers, patients, payers and med tech innovators
Beware the Chokepoints - Regulatory and Reimbursing panel
Experts in med tech regulation, reimbursement and intellectual property explain how to navigate the commercialization process
What I Know That I Wish I Knew - Innovators Panel
Med tech innovators and entrepreneurs share their early mistakes and surprises, and how they could be avoided
Predicting Med Tech Success - Valuation Lab
A case study from the Medical Industry Leadership Institute valuation lab that illustrates how to assess med tech business potential